Literature DB >> 25030784

Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.

Pamela L Lutsey1, Alvaro Alonso1, Erin D Michos1, Laura R Loehr1, Brad C Astor1, Josef Coresh1, Aaron R Folsom1.   

Abstract

BACKGROUND: Heart failure (HF) is a major source of morbidity and mortality, particularly among the elderly. Magnesium, phosphorus, and calcium are micronutrients traditionally viewed in relation to bone health or chronic kidney disease. However, they also may be associated with risk of cardiovascular disease through a broad range of physiologic roles.
OBJECTIVE: With the use of data from the Atherosclerosis Risk in Communities (ARIC) cohort, we tested the hypotheses that the incidence of HF is greater among individuals with low serum magnesium and those with high serum phosphorus and calcium.
DESIGN: A total of 14,709 African Americans (27%) and whites from the ARIC cohort [aged 45-64 y at baseline (1987-1989)] were observed through 2009. Proportional hazards regression was used to explore associations between biomarkers and incident HF. Serum calcium was corrected for serum albumin. Models were adjusted for demographics, behaviors, and physiologic characteristics.
RESULTS: A total of 2250 incident HF events accrued over a median follow-up of 20.6 y. Participants in the lowest (≤1.4 mEq/L) compared with the highest (≥1.8 mEq/L) category of magnesium were at greater HF risk (HR: 1.71; 95% CI: 1.46, 1.99). For phosphorus, there appeared to be a threshold whereby only those in the highest quintile were at greater HF risk [HR(Q5 vs Q1): 1.34; 95% CI: 1.16, 1.54]. Higher concentrations of calcium were also associated with greater risk of HF [HR(Q5 vs Q1): 1.24; 95% CI: 1.07, 1.43]. Results were not modified by race, sex, or kidney function and were similar when incident coronary heart disease was included as a time-varying covariate.
CONCLUSIONS: Low serum magnesium and high serum phosphorus and calcium were independently associated with greater risk of incident HF in this population-based cohort. Whether these biomarkers will be useful candidates for HF risk prediction or targets for prevention remains to be seen.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25030784      PMCID: PMC4135486          DOI: 10.3945/ajcn.114.085167

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  47 in total

1.  Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence.

Authors:  Aaron R Folsom; Hiroshi Yatsuya; Jennifer A Nettleton; Pamela L Lutsey; Mary Cushman; Wayne D Rosamond
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

2.  The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

Authors:  Benjamin D Parker; Leon J Schurgers; Vincent M Brandenburg; Robert H Christenson; Cees Vermeer; Markus Ketteler; Michael G Shlipak; Mary A Whooley; Joachim H Ix
Journal:  Ann Intern Med       Date:  2010-05-18       Impact factor: 25.391

3.  Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community.

Authors:  Ravi Dhingra; Philimon Gona; Emelia J Benjamin; Thomas J Wang; Jayashri Aragam; Ralph B D'Agostino; William B Kannel; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08       Impact factor: 15.534

4.  Prevalence of hypomagnesemia (HM) in a geriatric long-term care (LTC) setting.

Authors:  Zeev Arinzon; Alexander Peisakh; Samuel Schrire; Yitshal Neor Berner
Journal:  Arch Gerontol Geriatr       Date:  2009-08-07       Impact factor: 3.250

Review 5.  Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events.

Authors:  Lu Wang; JoAnn E Manson; Yiqing Song; Howard D Sesso
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

Review 6.  Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Suetonia C Palmer; Andrew Hayen; Petra Macaskill; Fabio Pellegrini; Jonathan C Craig; Grahame J Elder; Giovanni F M Strippoli
Journal:  JAMA       Date:  2011-03-16       Impact factor: 56.272

7.  Serum magnesium and risk of sudden cardiac death in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  James M Peacock; Tetsuya Ohira; Wendy Post; Nona Sotoodehnia; Wayne Rosamond; Aaron R Folsom
Journal:  Am Heart J       Date:  2010-09       Impact factor: 4.749

8.  Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study.

Authors:  Tetsuya Ohira; James M Peacock; Hiroyasu Iso; Lloyd E Chambless; Wayne D Rosamond; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2009-04-16       Impact factor: 4.897

9.  Magnesium administration may improve heart rate variability in patients with heart failure.

Authors:  D Almoznino-Sarafian; G Sarafian; S Berman; M Shteinshnaider; I Tzur; N Cohen; O Gorelik
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-02-07       Impact factor: 4.222

Review 10.  Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Authors:  Mark J Bolland; Alison Avenell; John A Baron; Andrew Grey; Graeme S MacLennan; Greg D Gamble; Ian R Reid
Journal:  BMJ       Date:  2010-07-29
View more
  57 in total

1.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

2.  Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events.

Authors:  Jun Ling Lu; Miklos Z Molnar; Jennie Z Ma; Lekha K George; Keiichi Sumida; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Clin Endocrinol Metab       Date:  2016-09-15       Impact factor: 5.958

3.  Novel effects of phytoestrogenic soy isoflavones on serum calcium and chloride in premenopausal women: A 2-year double-blind, randomized, placebo-controlled study.

Authors:  Lee-Jane W Lu; Nai-Wei Chen; Fatima Nayeem; V-M Sadagopa Ramanujam; Yong-Fang Kuo; Donald G Brunder; Manubai Nagamani; Karl E Anderson
Journal:  Clin Nutr       Date:  2017-11-11       Impact factor: 7.324

Review 4.  Interpreting magnesium status to enhance clinical care: key indicators.

Authors:  Rebecca B Costello; Forrest Nielsen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2017-11       Impact factor: 4.294

Review 5.  Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.

Authors:  Julia J Scialla
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

6.  Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.

Authors:  Jiachuan Xiong; Ting He; Min Wang; Ling Nie; Ying Zhang; Yiqin Wang; Yunjian Huang; Bing Feng; Jingbo Zhang; Jinghong Zhao
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

7.  Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study.

Authors:  Setor K Kunutsor; Hassan Khan; Jari A Laukkanen
Journal:  Eur J Epidemiol       Date:  2016-05-25       Impact factor: 8.082

8.  Prospective Association of Serum and Dietary Magnesium with Colorectal Cancer Incidence.

Authors:  Elizabeth J Polter; Guillaume Onyeaghala; Pamela L Lutsey; Aaron R Folsom; Corinne E Joshu; Elizabeth A Platz; Anna E Prizment
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-05       Impact factor: 4.254

Review 9.  Magnesium and cardiovascular complications of chronic kidney disease.

Authors:  Ziad A Massy; Tilman B Drüeke
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 10.  Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity.

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Bonekey Rep       Date:  2015-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.